Meeting
2020 ASCO Virtual Scientific Program
CD3 and CD20 immune cell densities in primary tumors, lymph node metastasis, and recurrent disease samples of head and neck squamous cell carcinoma.
Authors
Simon Laban
Department of Otolaryngology - Head and Neck Surgery, University Hospital Ulm, Universität Ulm, Ulm, Germany
Simon Laban , Romain Remark , Christian Idel , Julika Ribbat-Idel , Andreas Schröck , Jasmin Ezić , Johannes Döscher , Marie-Nicole Theodoraki , Rosemarie Krupar , Andrew G. Sikora , Glen Kristiansen , Friedrich Bootz , Guray Akturk , Thomas Jens Ettrich , Hazem Edmond El-Osta , Patrick J Schuler , Cornelia Brunner , Thomas K Hoffmann , Sven Perner , Sacha Gnjatic
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 6551)
DOI
10.1200/JCO.2020.38.15_suppl.6551
Abstract #
6551
Poster Bd #
212
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Prognostic impact of tumor-associated B cells and plasma cells in colorectal cancer.
First Author: Jonna Berntsson
Poster
2023 ASCO Annual Meeting
Introduction of E-Score: A gene expression score to characterize immunogenic versus oncogenic HPV expression in HNSCC.
First Author: Bailey Fabiny Garb
Poster
2023 ASCO Annual Meeting
Abemaciclib in recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC) harboring CDKN2A loss, and/or CCND1 and/or CDK6 amplification: A phase II multicenter trial.
First Author: Jerome Fayette
Poster
2022 ASCO Annual Meeting
Tumor cell budding as a prognostic and potentially therapeutically targetable biomarker in head and neck cancer.
First Author: Jan Budczies